UBS Reports Improved Interim Profit for BRILLIANCE CHI (01114.HK); Target Price Increased to $3.4
Financial Performance: BRILLIANCE CHI reported a 15% year-on-year increase in net profit for the first half of 2025, reaching RMB1.7 billion, with a 5% increase from the previous half.
Normalized Income Expectations: UBS anticipates the company's normalized net income to be RMB1.952 billion, which is expected to meet 62-68% of full-year projections, potentially prompting investors to adjust their estimates.
Profit Per Vehicle Growth: The net profit per vehicle improved by 24% quarter-on-quarter, amounting to RMB27,000, leading UBS to raise its net profit forecasts for FY2025-FY2027 by 10-20%.
Target Price Adjustment: UBS increased its target price for BRILLIANCE CHI from $3 to $3.4, reflecting a projected PE ratio of about 3x for 2026, maintaining a "Buy" rating on the stock.
Trade with 70% Backtested Accuracy
Analyst Views on 01114
About the author
<Alert> BRILLIANCE CHI Anticipates a Maximum 40% Decline in 2025 Net Profit
Stock Performance: Brilliance Chi (01114.HK) experienced a decline of 0.370, representing a drop of 9.814% in its stock price.
Short Selling Activity: The company has seen short selling amounting to $47.55 million, with a short selling ratio of 8.508%.
Profit Warning: Brilliance Chi issued a profit warning, anticipating a decrease in profit before income tax expense for the year ending December 2025 by not more than 50% year-over-year.
Market Implications: The profit warning and stock decline may impact investor confidence and market perception of Brilliance Chi's financial health.
<M Stanley Analysis> Ratings and Target Prices for Chinese Automakers (Table)
BYD Company Performance: BYD Company (01211.HK) saw a stock increase of 1.392% with a short selling ratio of 27.320%, and analysts maintain an "Overweight" rating with a target price of HK$126, highlighting advancements in their 2nd-Gen Blade Battery technology.
Geely Auto Update: Geely Auto (00175.HK) experienced a significant rise of 8.525% in stock price, with a short selling ratio of 17.295%, and is also rated "Overweight" with a target price of HK$25.
Other Automotive Stocks: GAC Group (02238.HK) and Dongfeng Group (00489.HK) are rated "Overweight" with minor stock increases, while BAIC Motor (01958.HK) faced a slight decline and is rated "Equalweight."
Analyst Ratings on BYD: Multiple analysts, including CICC and M Stanley, have reiterated their "Overweight" ratings on BYD, emphasizing its technological breakthroughs and the launch of the 2nd-Gen Blade Battery, which enables fast charging capabilities.
JPM Cuts BRILLIANCE CHI (01114.HK) Rating to Neutral, Expects Dividend Drop, Recommends Profit-Taking for Investors
JPMorgan's Cash Balance Estimate: JPMorgan forecasts that BRILLIANCE CHI will have a cash balance of approximately $1-1.5 per share by the end of the year, with an expected EPS of RMB0.64 and a potential dividend yield of 8-21%.
Dividend Concerns: Despite the attractive dividend level, JPMorgan warns that future dividends may decline due to reduced cash levels and ongoing challenges in the BMW Brilliance joint venture in China.
Earnings Forecast Adjustment: The broker has lowered its earnings forecasts for BRILLIANCE CHI by 11% for 2025 and 4% for 2026, reflecting concerns about the company's financial outlook.
Rating Downgrade: JPMorgan has downgraded BRILLIANCE CHI from Overweight to Neutral and reduced its target price from $4.7 to $4.1, advising investors to lock in profits.
<Full-day Summary> HSI Falls 331 Points; HSTI Declines 107 Points; XIAOMI Drops More Than 3%; BRILLIANCE CHI Reaches New Highs; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 331 points (1.3%) to close at 25,434, with significant declines also seen in the HSTI and HSCEI, while market turnover reached $210.24 billion.
Active Heavyweights: Major stocks like Xiaomi, Meituan, and Alibaba experienced notable declines, with Xiaomi dropping 3.1% and Alibaba down 1.6%, amidst high short selling ratios.
Significant Declines in Constituents: Xinyi Glass and Longfor saw substantial drops of 8.1% and 6% respectively, with several other companies also reporting significant losses in their stock prices.
Notable Gainers: Despite the overall market downturn, some stocks like Tanwan and Synagistics posted gains of over 10%, indicating pockets of resilience in the market.
Midday Update: HSI Ends at 25,549, Down 215 Points; HSTI at 5,587, Down 74 Points; XINYI GLASS Falls Over 6%; BRILLIANCE CHI Reaches New Highs
Market Performance: The Hang Seng Index (HSI) fell by 215 points (0.8%) to 25,549, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 1.3% and 1.1%, respectively.
Active Heavyweights: Major stocks like Xiaomi, Meituan, and Ping An saw declines, with Xiaomi dropping 2.7% and Ping An down 1.1%, amidst significant short selling activity.
Notable Declines: Xinyi Glass and Xinyi Solar faced substantial losses, with Xinyi Glass down 6.2% and Xinyi Solar down 4.3%, reflecting a broader trend of declining stock prices among constituents.
Gainers in the Market: Wuxi Bio and Yixin were among the few gainers, with Wuxi Bio increasing by 3% and Yixin rising by 11.5%, indicating some positive movement in a generally bearish market.
Citi Maintains Buy Rating on BRILLIANCE CHI (01114.HK) and Increases Price Target to $4.8
Citi's Research Report: Citi has published a report on BRILLIANCE CHI (01114.HK), highlighting three growth drivers for the company in the upcoming year, including increased export sales of the "Jinbei" brand, rising domestic market share, and the adoption of industrial robots to enhance manufacturing efficiency.
Target Price Adjustment: The broker raised BRILLIANCE CHI's target price from HK$3.75 to HK$4.8, maintaining a Buy/High Risk rating, and forecasts a 4% month-over-month increase in Brilliance BMW's retail sales for November, projecting a total of 46,000 units sold.
<Alert> BRILLIANCE CHI Anticipates a Maximum 40% Decline in 2025 Net Profit
Stock Performance: Brilliance Chi (01114.HK) experienced a decline of 0.370, representing a drop of 9.814% in its stock price.
Short Selling Activity: The company has seen short selling amounting to $47.55 million, with a short selling ratio of 8.508%.
Profit Warning: Brilliance Chi issued a profit warning, anticipating a decrease in profit before income tax expense for the year ending December 2025 by not more than 50% year-over-year.
Market Implications: The profit warning and stock decline may impact investor confidence and market perception of Brilliance Chi's financial health.
<M Stanley Analysis> Ratings and Target Prices for Chinese Automakers (Table)
BYD Company Performance: BYD Company (01211.HK) saw a stock increase of 1.392% with a short selling ratio of 27.320%, and analysts maintain an "Overweight" rating with a target price of HK$126, highlighting advancements in their 2nd-Gen Blade Battery technology.
Geely Auto Update: Geely Auto (00175.HK) experienced a significant rise of 8.525% in stock price, with a short selling ratio of 17.295%, and is also rated "Overweight" with a target price of HK$25.
Other Automotive Stocks: GAC Group (02238.HK) and Dongfeng Group (00489.HK) are rated "Overweight" with minor stock increases, while BAIC Motor (01958.HK) faced a slight decline and is rated "Equalweight."
Analyst Ratings on BYD: Multiple analysts, including CICC and M Stanley, have reiterated their "Overweight" ratings on BYD, emphasizing its technological breakthroughs and the launch of the 2nd-Gen Blade Battery, which enables fast charging capabilities.
JPM Cuts BRILLIANCE CHI (01114.HK) Rating to Neutral, Expects Dividend Drop, Recommends Profit-Taking for Investors
JPMorgan's Cash Balance Estimate: JPMorgan forecasts that BRILLIANCE CHI will have a cash balance of approximately $1-1.5 per share by the end of the year, with an expected EPS of RMB0.64 and a potential dividend yield of 8-21%.
Dividend Concerns: Despite the attractive dividend level, JPMorgan warns that future dividends may decline due to reduced cash levels and ongoing challenges in the BMW Brilliance joint venture in China.
Earnings Forecast Adjustment: The broker has lowered its earnings forecasts for BRILLIANCE CHI by 11% for 2025 and 4% for 2026, reflecting concerns about the company's financial outlook.
Rating Downgrade: JPMorgan has downgraded BRILLIANCE CHI from Overweight to Neutral and reduced its target price from $4.7 to $4.1, advising investors to lock in profits.
<Full-day Summary> HSI Falls 331 Points; HSTI Declines 107 Points; XIAOMI Drops More Than 3%; BRILLIANCE CHI Reaches New Highs; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 331 points (1.3%) to close at 25,434, with significant declines also seen in the HSTI and HSCEI, while market turnover reached $210.24 billion.
Active Heavyweights: Major stocks like Xiaomi, Meituan, and Alibaba experienced notable declines, with Xiaomi dropping 3.1% and Alibaba down 1.6%, amidst high short selling ratios.
Significant Declines in Constituents: Xinyi Glass and Longfor saw substantial drops of 8.1% and 6% respectively, with several other companies also reporting significant losses in their stock prices.
Notable Gainers: Despite the overall market downturn, some stocks like Tanwan and Synagistics posted gains of over 10%, indicating pockets of resilience in the market.
Midday Update: HSI Ends at 25,549, Down 215 Points; HSTI at 5,587, Down 74 Points; XINYI GLASS Falls Over 6%; BRILLIANCE CHI Reaches New Highs
Market Performance: The Hang Seng Index (HSI) fell by 215 points (0.8%) to 25,549, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 1.3% and 1.1%, respectively.
Active Heavyweights: Major stocks like Xiaomi, Meituan, and Ping An saw declines, with Xiaomi dropping 2.7% and Ping An down 1.1%, amidst significant short selling activity.
Notable Declines: Xinyi Glass and Xinyi Solar faced substantial losses, with Xinyi Glass down 6.2% and Xinyi Solar down 4.3%, reflecting a broader trend of declining stock prices among constituents.
Gainers in the Market: Wuxi Bio and Yixin were among the few gainers, with Wuxi Bio increasing by 3% and Yixin rising by 11.5%, indicating some positive movement in a generally bearish market.
Citi Maintains Buy Rating on BRILLIANCE CHI (01114.HK) and Increases Price Target to $4.8
Citi's Research Report: Citi has published a report on BRILLIANCE CHI (01114.HK), highlighting three growth drivers for the company in the upcoming year, including increased export sales of the "Jinbei" brand, rising domestic market share, and the adoption of industrial robots to enhance manufacturing efficiency.
Target Price Adjustment: The broker raised BRILLIANCE CHI's target price from HK$3.75 to HK$4.8, maintaining a Buy/High Risk rating, and forecasts a 4% month-over-month increase in Brilliance BMW's retail sales for November, projecting a total of 46,000 units sold.
